EN
登录

WELL Health宣布因美国子公司 Circle Medical相关事项,年度审计财务报表的提交将延迟

WELL Health Announces Delay in Filing of Annual Audited Financial Statements Due to Matter Related to US Subsidiary Circle Medical

CISION 等信源发布 2025-03-29 08:22

可切换为仅中文


VANCOUVER, BC

加拿大温哥华

,

March 28, 2025

2025年3月28日

/PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX:

/PRNewswire/ - WELL健康科技公司(多伦多证券交易所:WELL)(OTCQX:

WHTCF

白色恐怖受害者补偿基金会

) ('

) ('

WELL

' or the '

' 或者 '

Company

公司

'), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces that it will be delaying the filing of its audited annual consolidated financial statements for the year ended December 31, 2024, the related management's discussion and analysis, and related CEO and CFO certificates (collectively, the '.

“),这家专注于通过技术手段赋能全球医疗从业者及其患者,从而对健康结果产生积极影响的数字医疗公司宣布,将延迟提交截至2024年12月31日的经审计年度合并财务报表、相关的管理层讨论与分析以及相关的首席执行官和首席财务官证书(统称为‘”。

Required Filings

必需的文件提交

') beyond the

') 超出

March 31, 2025

2025年3月31日

deadline (the '

截止日期(“

Deadline

截止日期

').

')。

The delay is resulting from the accounting implications related to the Company's non-wholly owned

延迟是由于与公司非全资相关的会计影响所致。

Delaware

特拉华州

subsidiary Circle Medical Technologies, Inc. ('

子公司Circle Medical Technologies, Inc.(

Circle

Medical

医学的

'), as described in further detail below. In fiscal 2023, Circle Medical contributed a net loss of

“),如下文所述。在2023财年,Circle Medical贡献了净亏损”

$1.1 million

110万美元

to WELL's consolidated net income of

归属于WELL的合并净利润

$16.6 million

1660万美元

and contributed less than 2.7% to WELL's consolidated Adjusted EBITDA

并且对WELL的合并调整后EBITDA贡献不到2.7%

(1)

(1)

.

In

September 2024

2024年9月

, Circle Medical received a request for the voluntary production of documents and information ('

,Circle Medical 收到了一份要求自愿提供文件和信息的请求(

RFI

射频干扰

') from the Civil Division of

') 来自民事部门的

the United States

美国

Attorney's Office for the Northern District of

北方地区司法局

California

加利福尼亚州

('

('

USAO

美国律师办公室

') investigating certain of Circle Medical's billing practices in the US. Circle Medical has been responding to the RFI and engaging with the USAO to address and resolve this matter.  Additional information and analysis regarding the impact of the USAO RFI is necessary in order to finalise Circle Medical's financial statements and by extension, the Company's annual consolidated financial statements for the year ended .

') 调查Circle Medical在美国的某些计费操作。Circle Medical一直在回应RFI,并与USAO合作解决和处理此事。为了最终确定Circle Medical的财务报表,以及延伸而言公司的年度合并财务报表,有必要进一步获取和分析与USAO RFI影响相关的信息。

December 31, 2024

2024年12月31日

. The production of information by Circle Medical and analysis by the Company for the financial statements is not expected to be completed prior to the

Circle Medical 的信息生成以及公司为财务报表进行的分析预计不会在之前完成。

March 31, 2025

2025年3月31日

filing deadline for the Required Filings.

必要文件的提交截止日期。

The Company does not expect the resolution of the matter to have a material effect on the Company's cash position or available resources. The Company and Circle Medical are currently working diligently to finalise the Company's annual consolidated financial statements at the earliest possible date. The Company currently expects to be in a position to file the Required Filings on or before April 15, 2025 (the '.

公司预计该问题的解决不会对公司的现金状况或可用资源产生重大影响。公司和Circle Medical目前正在努力尽快完成公司的年度合并财务报表。公司目前预计能够在2025年4月15日或之前提交所需的文件。

Filing Interval

申报间隔

').

`').`

Notwithstanding the foregoing, the Company confirms that it continues to seek strategic alternatives for Circle Medical and is committed to carrying out this process in due course.

尽管有上述情况,公司确认其仍在为Circle Medical寻求战略替代方案,并致力于在适当的时候推进这一进程。

The Company has applied to the British Columbia Securities Commission, as principal regulator for the Company, for the imposition of a management cease trade order under National Policy 12-203 –

公司已向不列颠哥伦比亚省证券委员会(作为公司的主要监管机构)申请根据国家政策12-203实施管理层停止交易令——

Management Cease Trade Orders

管理层停止交易令

('

('

NP 12-203

NP 12-203

') throughout the duration of the Filing Interval. However, there can be no assurance that a management cease trade order will be granted. The management cease trade order, if approved, will not affect the ability of persons who are not or have not been management of the Company to trade in its securities..

`)在整个申报期间。然而,不能保证一定会获得管理层停止交易令。如果管理层停止交易令获得批准,它将不会影响非公司管理层人员或不再是公司管理层人员交易其证券的能力。`

WELL confirms that it will satisfy the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly default status reports, if necessary, in the form of news releases for so long as it remains in default of the above-noted filing requirements. The British Columbia Securities Commission may issue a general cease trade order against WELL for failure to file the Required Filings within the prescribed time period or sooner if WELL fails to file the prescribed status reports..

WELL 确认,如果有必要,它将通过发布每两周一次的默认状态报告(以新闻稿的形式)来满足 NP 12-203 下的替代信息指南的规定,只要它仍然不符合上述文件要求。如果 WELL 未能在规定的时间内提交所需文件,或未能按时提交规定的状态报告,不列颠哥伦比亚证券委员会可能会对 WELL 发出全面停止交易令。

Other than as disclosed herein, WELL is up to date in its filing obligations.

除本文所披露的内容外,WELL 已履行其备案义务。

Footnote:

脚注:

1.

1.

Non-GAAP Financial Measures – Adjusted EBITDA

非公认会计准则财务指标——调整后的息税折旧摊销前利润

In addition to results reported in accordance with IFRS, the Company uses Adjusted EBITDA as a supplemental indicator of its financial and operating performance. The Company believes this non-GAAP financial measure reflects the Company's ongoing business in a manner that allows for meaningful period-to-period comparisons and analysis of trends in its business.

除按照国际财务报告准则报告的结果外,公司还使用调整后的息税折旧摊销前利润(Adjusted EBITDA)作为其财务和运营绩效的补充指标。公司认为,这一非公认会计原则财务指标以一种能够进行有意义的期间对比和业务趋势分析的方式反映了公司的持续经营状况。

The Company defines Adjusted EBITDA as net income (loss) before interest, taxes, depreciation and amortization less (i) net rent expense on premise leases considered to be finance leases under IFRS and before (ii) transaction, restructuring, and integration costs, time-based earn-out expense, change in fair value of investments, share of income (loss) of associates, foreign exchange gain/loss, and stock-based compensation expense, and (iii) gains/losses that are not reflective of ongoing operating performance.

公司定义的调整后息税折旧摊销前利润(Adjusted EBITDA)为:在利息、税项、折旧和摊销前的净收入(亏损),减去(i)根据国际财务报告准则(IFRS)被视为融资租赁的经营租赁的净租金支出,并在(ii)交易、重组和整合成本、基于时间的或有对价支出、投资公允价值变动、联营公司损益份额、外汇损益以及股票薪酬支出之前,以及(iii)不反映持续经营业绩的收益/损失。

The Company considers Adjusted EBITDA to be a financial metric that measures cash flow that can be used to fund working capital requirements, service future interest and principal debt repayments, and fund future growth initiatives. Adjusted EBITDA should not be considered an alternative to net income (loss), cash flow from operating activities, or other measures of financial performance defined under IFRS.

公司认为,调整后的息税折旧摊销前利润(Adjusted EBITDA)是一项财务指标,用于衡量可用于满足营运资金需求、支付未来利息和本金债务偿还以及资助未来增长计划的现金流。调整后的息税折旧摊销前利润不应被视为净利润(亏损)、经营活动产生的现金流量或根据国际财务报告准则(IFRS)定义的其他财务绩效指标的替代品。

A reconciliation of Adjusted EBITDA to the most directly comparable IFRS measure can be found in the Company's Fiscal 2023 Annual MD&A..

可以在公司2023财年年度MD&A中找到调整后EBITDA与最直接可比的IFRS指标的对账。

WELL HEALTH TECHNOLOGIES CORP.

威尔健康科技公司

Per: 'Hamed Shahbazi'

每:'哈梅德·沙赫巴齐'

Hamed Shahbazi

哈米德·沙巴齐

Chief Executive Officer, Chairman and Director

首席执行官、董事长和董事

About WELL Health Technologies Corp.

关于WELL健康科技公司

WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices.

WELL 的使命是通过技术赋能医疗保健提供者。我们通过开发最优质的技术、服务和支持来实现这一目标,确保医疗保健提供者能够有效地对患者的健康结果产生积极影响。WELL 全面的医疗保健和数字平台包括广泛的前台和后台管理软件应用,帮助医生运营和保护他们的诊所。

WELL's solutions enable more than 41,000 healthcare providers between the US and .

WELL的解决方案为美国境内的41,000多家医疗服务提供商提供支持。

Canada

加拿大

and power the largest owned and operated healthcare ecosystem in

并为最大的自有和运营的医疗保健生态系统提供动力

Canada

加拿大

with more than 200 clinics supporting primary care, specialized care, and diagnostic services. In

拥有200多家诊所,支持初级保健、专科护理和诊断服务。在

the United States

美国

WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about the Company, please visit: .

WELL的解决方案专注于胃肠病市场、女性健康、初级保健和心理健康等专业市场。WELL在多伦多证券交易所公开上市,股票代码为“WELL”,并在OTC交易所上市,股票代码为“WHTCF”。欲了解更多信息,请访问公司网站:。

www.well.company

www.well.company

.

Forward-Looking Information

前瞻性信息

This news release contains 'Forward-Looking Information' within the meaning of applicable Canadian securities laws, including, without limitation: statements regarding the grant of a management cease trade order, expected timing of the Required Filings, the impact of the resolution of the USAO RFI on WELL, and the ability to consummate strategic alternatives for Circle Medical.

本新闻稿包含适用的加拿大证券法定义下的“前瞻性信息”,包括但不限于:关于授予管理层停止交易令的声明、预期的必要文件提交时间、美国律师协会请求信息的解决对WELL的影响,以及完成Circle Medical战略替代方案的能力。

Forward-Looking Information is based on a number of estimates and assumptions are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond WELL's control, which could cause actual results and events to differ materially from those disclosed in this news release.

前瞻性信息基于许多估计和假设,这些估计和假设本质上受到重大商业、经济和竞争的不确定性和偶发事件的影响,其中许多因素超出WELL的控制范围,可能导致实际结果和事件与此新闻稿中披露的内容存在重大差异。

Forward-Looking Information generally can be identified by the use of forward-looking words such as 'may', 'should', 'will', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe', 'goal' or 'continue', or the negative thereof or similar variations. Forward-Looking Information involves known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information is not a guarantee of future results or performance.

前瞻性信息通常可以通过使用前瞻性词语来识别,例如“可能”、“应该”、“将”、“能够”、“意图”、“估计”、“计划”、“预期”、“相信”、“目标”或“继续”,或其否定形式或类似变体。前瞻性信息涉及已知和未知的风险、不确定性和其他因素,这些因素可能导致未来结果、表现或成就与前瞻性信息所表达或暗示的估计未来结果、表现或成就存在重大差异,并且前瞻性信息并非对未来结果或表现的保证。

WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including the risk factors identified in documents filed by WELL under its profile at .

WELL的前瞻性信息中表达或暗示的评论受到许多风险、不确定性和条件的影响,其中许多因素是WELL无法控制的,不应过度依赖此类信息。前瞻性信息整体上受到固有风险和不确定性的影响,包括WELL在其档案中提交的文件中列出的风险因素。

www.sedar.com

www.sedar.com

, including its most recent Annual Information Form and its most recent Management's Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.

,包括其最近的年度信息表和最近的管理层讨论与分析。除非证券法要求,WELL不承担任何更新或修改任何前瞻性信息的义务,无论是由于新信息、事件或其他原因。

SOURCE WELL Health Technologies Corp.

源井健康科技公司

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM?

440k+

44万+

Newsrooms &

新闻编辑室 &

Influencers

影响者

9k+

9k+

Digital Media

数字媒体

Outlets

插座

270k+

27万+

Journalists

记者

Opted In

已选择加入

GET STARTED

开始使用